Skip to main content
. 2014 Aug 22;57(21):8860–8879. doi: 10.1021/jm500942v

Figure 5.

Figure 5

Abbreviated (three time-point) plasma exposure profiles for four frontrunner compounds in Swiss outbred mice following oral administration as PEG400 suspensions at 10 mg/kg: (●) 52, (△) 66, (■) 67, and (◇) 7.